Medochemie Africa BI
Command Dashboard
Uganda, 2026, through April
Module M1
YTD Revenue
€239,908
50,551 units sold
Annual Target
€801,409
29.9% achieved
Pace vs Linear
-3.4%
4/12 months of data
Active Customers
133
Avg €244.55 / txn
Monthly Revenue
EUR by sale monthPartner Split
YTD revenueZawadi Pharma Distributors€142,927
416 transactions€344 avg
Amara Distribution Ltd€96,981
565 transactions€172 avg
By Therapeutic Category
YTD revenueBy Customer Segment
YTD revenueTop Products
Top 10 by YTD revenue| SKU | Category | Revenue YTD | Units | vs Target |
|---|---|---|---|---|
| FOLIVITA 2G 10'S | ANTI-INFECTIVES | €33,742 | 835 | 41.8% |
| CARDINEX 1G 1'S | ANTI-INFECTIVES | €31,714 | 5,107 | 36.5% |
| NIFEDOR 400MG | ANTI-INFECTIVES | €27,097 | 6,948 | 57.9% |
| BETASOL 625MG | ANTI-INFECTIVES | €17,902 | 3,214 | 91.9% |
| METFOREN 750MG 10'S | ANTI-INFECTIVES | €17,720 | 979 | 139.8% |
| METFOREN 500MG | ANTI-INFECTIVES | €17,181 | 3,485 | 87.2% |
| FOLIVITA 1G | ANTI-INFECTIVES | €15,150 | 8,189 | 41.0% |
| NORVACIN 1G 10'S | ANTI-INFECTIVES | €11,896 | 829 | 33.2% |
| NIFEDOR 200MG | ANTI-INFECTIVES | €9,506 | 3,359 | 51.7% |
| INSUVEN 25MG | CARDIOVASCULAR | €7,473 | 2,166 | 18.1% |